GlassScriptPhysician profile
James Christopher Xenophon
NPI 1265430334
$2,503.67
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $128 · 2021: $445 · 2022: $468 · 2023: $880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.10 |
| Education | $159.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $771.91 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Astellas Pharma US INC | $344.41 | 2019-2023 | Veozah, Myrbetriq |
| Pfizer INC. | $229.35 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $196.39 | 2023 | Gemtesa, Myfembree |
| Urovant Sciences INC | $116.49 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.60 | 2019-2023 | |
| Therapeuticsmd, INC. | $100.18 | 2019-2022 | |
| Exeltis, USA INC. | $79.32 | 2021-2023 | Slynd |
| Merck Sharp & Dohme LLC | $64.14 | 2019-2023 | Gardasil 9 |
| Axonics, INC. | $59.88 | 2022-2023 | Axonics |
| Myovant Sciences INC. | $54.21 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $52.41 | 2019-2020 | |
| Allergan, INC. | $47.57 | 2019 | |
| Avion Pharmaceuticals | $44.36 | 2021 | |
| Evofem Biosciences, INC. | $44.12 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $30.91 | 2022-2023 | |
| Coopersurgical, INC. | $25.56 | 2023 | Endosee |
| Hologic Sales and Service, LLC | $24.89 | 2019-2023 | Thinprep 2000 Processor, Affirm Prone Biopsy System, Aptima |
| Organon LLC | $19.85 | 2021-2022 | |
| Agile Therapeutics, INC. | $16.57 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.04 | 2022 | |
| Amgen INC. | $15.70 | 2020 | |
| Exact Sciences Corporation | $13.51 | 2023 | Cologuard Collection Kit |
| Radius Health, INC. | $13.49 | 2023 | Tymlos |
| Sage Therapeutics, LLC | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Xenophon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.